Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-03-04 Stark David Matthew Exec. VP Chief Legal Officer Sale −13,930 $10.57 $147K 2,974.39
2021-03-04 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −13,930 27,861
2021-03-04 Schultz Kare President and CEO Option exercise +59,701 860,582
2021-03-04 Schultz Kare President and CEO Option exercise · Restricted Share Units −59,701 119,403
2021-03-04 Sabag Mark See "Remarks" below Option exercise +15,920 147,842
2021-03-04 Sabag Mark See "Remarks" below Option exercise · Restricted Share Units −15,920 31,841
2021-03-04 O'Grady Brendan P. EVP, North America Commercial Sale −703 $10.80 $8K 14,868.49
2021-03-04 O'Grady Brendan P. EVP, North America Commercial Option exercise +18,905 33,773.49
2021-03-04 O'Grady Brendan P. EVP, North America Commercial Sale −7,469 $10.57 $79K 26,304.49
2021-03-04 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −18,905 37,811
2021-03-04 Nazzi Gianfranco EVP, International Markets Grant or award +12,935 12,935
2021-03-04 Nazzi Gianfranco EVP, International Markets Sale −12,935 $10.58 $137K 0
2021-03-04 Nazzi Gianfranco EVP, International Markets Option exercise · Restricted Share Units −12,935 25,870
2021-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +18,905 82,968.51
2021-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Sale −9,515 $10.57 $101K 73,453.51
2021-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −18,905 37,811
2021-03-04 Drape Eric Executive VP Global Operations Option exercise +11,940 61,231
2021-03-04 Drape Eric Executive VP Global Operations Sale −6,183 $10.58 $65K 55,048
2021-03-04 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units −11,940 23,880
2021-03-04 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise +13,930 83,987.7

Page 47 of 76 · 1,517 trades